Process for the preparation of a crystalline hydrated form of the compound bis(e)-1-[4-(4 flourophenyl)-6-isopropyl-2-[methyl (methylsulfonyl) amino] pyrimidin-5 yl](3r, 5s)-3,5-dihydroxyhept-6-enoic acid]calcium salt
PK201000547A0Undetermined Publication Date: 2010-07-07ASTRAZENECA UK LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000547
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2010-06-22
- Publication Date
- 2010-07-07
Abstract
The invention relates to the process of making two polymorphic form of BIS(E)-7-[4-(4-flourophenyl)-6 isopropyl-2 [methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5dihydroxyhept-6-enoic acid]calcium salt and its use as HMG Co-A reductase inhibitors are described.
Need to check novelty before this filing date? Find Prior Art